Use of Subclavian Extracorporeal Carbon Dioxide Removal for COVID-19 Acute Respiratory Distress Syndrome as a Bridge to Lung Transplantation.
暂无分享,去创建一个
I. Gregoric | B. Akkanti | B. Kar | R. Hussain | K. Dinh | Sukhdeep S Basra | M. Patel
[1] G. Perkins,et al. Effect of Lower Tidal Volume Ventilation Facilitated by Extracorporeal Carbon Dioxide Removal vs Standard Care Ventilation on 90-Day Mortality in Patients With Acute Hypoxemic Respiratory Failure: The REST Randomized Clinical Trial. , 2021, JAMA.
[2] Xiaowei Yan,et al. ECCO2R in 12 COVID-19 ARDS Patients With Extremely Low Compliance and Refractory Hypercapnia , 2021, Frontiers in Medicine.
[3] John M Litell,et al. Treatment of Severe Hypercapnic Respiratory Failure Caused by SARS-CoV-2 Lung Injury with ECCO2R Using the Hemolung Respiratory Assist System , 2021, Case Reports in Critical Care.
[4] J. Richecoeur,et al. Feasibility and safety of ultra-low tidal volume ventilation without extracorporeal circulation in moderately severe and severe ARDS patients , 2019, Intensive Care Medicine.
[5] J. Sznajder,et al. Severe hypercapnia and outcome of mechanically ventilated patients with moderate or severe acute respiratory distress syndrome , 2017, Intensive Care Medicine.
[6] P. Kalfon,et al. Intravascular Complications of Central Venous Catheterization by Insertion Site. , 2015, The New England journal of medicine.
[7] H. Teschler,et al. Avoidance of intubation during acute exacerbation of chronic obstructive pulmonary disease for a lung transplant candidate using extracorporeal carbon dioxide removal with the Hemolung. , 2013, The Journal of thoracic and cardiovascular surgery.
[8] L. Gattinoni,et al. THE CARBON DIOXIDE MEMBRANE LUNG (CDML): A NEW CONCEPT , 1977, Transactions - American Society for Artificial Internal Organs.